Zymeworks
ZYMEZymeworks is a global biotechnology company focused on the discovery, development, and commercialization of multifunctional biotherapeutics for difficult-to-treat diseases.
Earnings
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$14.7M
EPS estimate-$0.49
Valuation & ratios
Competitors
By market cap
By revenue growth
By net margin
Profile
Zymeworks is a global biotechnology company focused on the discovery, development, and commercialization of multifunctional biotherapeutics for difficult-to-treat diseases. The company leverages proprietary protein engineering and antibody-drug conjugate platforms to build a pipeline of next-generation therapies while employing an asset and royalty aggregation strategy to generate long-term cash flows.
Competitive position
Zymeworks differentiates itself through a dual-track model of internal protein engineering innovation and a disciplined royalty-bearing partnership strategy.
GeographiesGlobal
Customer segmentsGlobal pharmaceutical companies, Healthcare providers
Business modelIP Licensing, R&D, Royalty Aggregation
SuppliersMolecular modeling software, Laboratory equipment suppliers, Contract research organizations, Raw material suppliers for drug chemistry
CustomersLarge-cap pharmaceutical companies, Specialty oncology clinics, Hospitals, Healthcare payers
CountryCanada
Listed2017
Employees275.0
CEOKenneth H. Galbraith
SectorHealthcare
IndustryBiotechnology
Websitezymeworks.com
FilingsSEC EDGAR
Questions, answered.
- What is Zymeworks's market cap?
- Zymeworks (ZYME) has a market capitalization of $1.7B and trades on NASDAQ.
- What is Zymeworks's revenue and profitability?
- Zymeworks generated $81.3M in trailing twelve-month revenue with a net loss of $102.7M, representing a net margin of -126.3%, with free cash flow of -$77.0M. These figures are based on the Q1 2026 filing.
- Who are Zymeworks's competitors?
- Zymeworks's key competitors include Amgen, Seagen, CDT Equity Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Zymeworks partner with?
- Zymeworks's notable partners include Jazz Pharmaceuticals, BeiGene.
- What subsidiaries does Zymeworks have?
- Zymeworks's subsidiaries include Zymeworks BC Inc..
- Where is Zymeworks headquartered?
- Zymeworks is headquartered in Canada and employs approximately 275 people. It has been publicly traded since 2017.
